These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24581558)

  • 1. Chagas disease: the challenge of polyparasitism?
    Perez CJ; Lymbery AJ; Thompson RC
    Trends Parasitol; 2014 Apr; 30(4):176-82. PubMed ID: 24581558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of genetic variability of Trypanosoma cruzi for the pathogenesis of Chagas disease.
    Manoel-Caetano Fda S; Silva AE
    Cad Saude Publica; 2007 Oct; 23(10):2263-74. PubMed ID: 17891288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chagas disease (Trypanosoma cruzi) and HIV co-infection in Colombia.
    Hernández C; Cucunubá Z; Parra E; Toro G; Zambrano P; Ramírez JD
    Int J Infect Dis; 2014 Sep; 26():146-8. PubMed ID: 25080354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of chagas disease.
    Macedo AM; Machado CR; Oliveira RP; Pena SD
    Mem Inst Oswaldo Cruz; 2004 Feb; 99(1):1-12. PubMed ID: 15057339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic and proteomic approaches for Chagas' disease: critical analysis of diagnostic methods.
    Huete-Pérez JA; Flores-Obando RE; Ghedin E; Caffrey CR
    Expert Rev Mol Diagn; 2005 Jul; 5(4):521-30. PubMed ID: 16013970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trypanosoma cruzi and Chagas disease: a proposal for a analysis of the genomic configuration in host-parasite interactions].
    Brandão A
    Rev Soc Bras Med Trop; 2006; 39 Suppl 3():112. PubMed ID: 17605218
    [No Abstract]   [Full Text] [Related]  

  • 7. The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease.
    Junqueira C; Caetano B; Bartholomeu DC; Melo MB; Ropert C; Rodrigues MM; Gazzinelli RT
    Expert Rev Mol Med; 2010 Sep; 12():e29. PubMed ID: 20840799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases.
    Ouaissi A; Ouaissi M
    Arch Immunol Ther Exp (Warsz); 2005; 53(2):102-14. PubMed ID: 15928579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease.
    DosReis GA
    Braz J Med Biol Res; 2011 Feb; 44(2):84-90. PubMed ID: 21243314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. kDNA gene signatures of Trypanosoma cruzi in blood and oesophageal mucosa from chronic chagasic patients.
    Manoel-Caetano Fda S; Carareto CM; Borim AA; Miyazaki K; Silva AE
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1102-7. PubMed ID: 18617206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chagas disease: role of parasite genetic variation in pathogenesis.
    Macedo AM; Oliveira RP; Pena SD
    Expert Rev Mol Med; 2002 Mar; 4(5):1-16. PubMed ID: 14987389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma cruzi infection beats the B-cell compartment favouring parasite establishment: can we strike first?
    Acosta Rodriguez EV; Zuniga EI; Montes CL; Merino MC; Bermejo DA; Amezcua Vesely MC; Motran CC; Gruppi A
    Scand J Immunol; 2007; 66(2-3):137-42. PubMed ID: 17635791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the role of dogs (Canis lupus familiaris) in the transmission dynamics of Trypanosoma cruzi genotypes in Colombia.
    Ramírez JD; Turriago B; Tapia-Calle G; Guhl F
    Vet Parasitol; 2013 Sep; 196(1-2):216-9. PubMed ID: 23351975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Evasion Strategies of Trypanosoma cruzi.
    Flávia Nardy A; Freire-de-Lima CG; Morrot A
    J Immunol Res; 2015; 2015():178947. PubMed ID: 26240832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?
    Lima FM; Oliveira P; Mortara RA; Silveira JF; Bahia D
    N Biotechnol; 2010 Dec; 27(6):837-43. PubMed ID: 20172059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosoma cruzi Produces the Specialized Proresolving Mediators Resolvin D1, Resolvin D5, and Resolvin E2.
    Colas RA; Ashton AW; Mukherjee S; Dalli J; Akide-Ndunge OB; Huang H; Desruisseaux MS; Guan F; Jelicks LA; Matos Dos Santos F; Nagajyothi J; Zingman MA; Reyes J; Weiss LM; Serhan CN; Tanowitz HB
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29358332
    [No Abstract]   [Full Text] [Related]  

  • 17. The Trypanosoma cruzi-host-cell interplay: location, invasion, retention.
    Andrade LO; Andrews NW
    Nat Rev Microbiol; 2005 Oct; 3(10):819-23. PubMed ID: 16175174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Host immune response to Trypanosoma cruzi and its evasion mechanism].
    Yamamoto M; Takeda K
    Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):1053-8. PubMed ID: 21089540
    [No Abstract]   [Full Text] [Related]  

  • 19. Rat models to investigate host macrophage defense against Trypanosoma cruzi.
    Fabrino DL; Leon LL; Genestra M; Parreira GG; Melo RC
    J Innate Immun; 2011; 3(1):71-82. PubMed ID: 21051863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection.
    Santos DM; Martins TA; Caldas IS; Diniz LF; Machado-Coelho GL; Carneiro CM; Oliveira Rde P; Talvani A; Lana M; Bahia MT
    Acta Trop; 2010 Feb; 113(2):134-8. PubMed ID: 19854145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.